ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullish•Quantitative Analysis
•13 Nov 2019 07:44

Korea - Shorts Cover as Market Rallies

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 8...

Logo
521 Views
Share
bearish•Quantitative Analysis
•01 Nov 2019 22:11

Korea Shorts Data Analysis (#1): Celltrion, Samsung Biologics, DS Infracore, HLB, & Hotel Shilla

This is our first inaugural edition of the Korea Shorts Data Analysis. We plan to make this into a regular piece. We broke down the Korean shorts...

Logo
504 Views
Share
bearish•Quantitative Analysis
•13 Sep 2019 08:23

Asia Short Interest - Scary Charts for Friday the 13th

In keeping with the day of the week and date, we look at some charts of short interest and price for stocks from Korea, Taiwan and Hong Kong.These...

Logo
877 Views
Share
•28 Aug 2019 13:51

The Week That Was @ Smartkarma in Korea, Japan, China/HK: Megvii, GSOMIA, Cho Kuk, & Sony

On August 22nd, the South Korean government announced that it has decided to terminate the GSOMIA (General Security of Military Information...

Logo
572 Views
Share
bearish•Quantitative Analysis
•27 Aug 2019 18:01

Korea Short Interest - Numb3rs & Ch@rts

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 23 August.Current...

Logo
555 Views
Share
x